Open an account

Proto Labs

PRLB · NYSE

$87.73+$0.33 (+0.38%)TodayMarket closed ·
Prev close $87.40

About PRLB

Proto Labs, Inc. engages in the manufacture of custom prototypes and production parts. The company is headquartered in Maple Plain, Minnesota and currently employs 2,280 full-time employees. The company went IPO on 2012-02-24. Its digital factories produce low-volume parts in days while Protolabs Network provides advanced capabilities and volume pricing through its manufacturing partners. Its services include injection molding, computer numerical control (CNC) machining, three-dimensional (3D) printing and sheet metal fabrication. Its injection molding services include plastic injection molding, liquid silicone rubber molding, and over molding and insert molding. Its CNC machining services include CNC milling, CNC turning, precision machining, threading options and finishing options. Its 3D printing services include metal 3D printing, multi jet fusion and advanced photopolymers. Its sheet metal fabrication services include laser cutting, punching, fabricated assemblies, and prototyping. The company serves various industries, including medical, robotics, aerospace, automotive, consumer electronics and industrial equipment.

Employees
2,280
Headquarters
Maple Plain, Minnesota
Listed
Feb 24, 2012
Sector
Industrials
Industry
Machinery
Website
protolabs.com

PRLB key statistics

Market cap
2.10B
Price-earnings ratio
69.92
Dividend yield
—
Average volume
223.03K
Volume
201.31K
Open price
$86.47
High today
$88.94
Low today
$85.20
52 Week high
$99.96
52 Week low
$45.10

Proto Labs (PRLB) at a glance

As of Oct 20, 2026, Proto Labs (PRLB) shares are priced at $87.73, giving the company a market cap of 2.10B and a price-to-earnings ratio of 69.92.

Today the stock has traded between $85.20 and $88.94. The current price is 3.0% above the day's low and 1.4% below its high.

Volume so far is 201.31K shares, in line with the average of 223.03K shares a day.

Over the past year Proto Labs has ranged from $45.10 to $99.96, and now sits 78% of the way up that range.

Proto Labs met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $0.60 per share against an estimate of $0.5481.

The average analyst price target is $97.41, 11.0% above the current price, from 2 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 2 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 6 analystsAvg $97.41
Low
$87.87
Now
$87.73
High
$115.50

PRLB earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 8 of the last 8 quarters, by 22.0% on average.

  1. Q3 FY24: reported $0.47 per share against an estimate of $0.3278
  2. Q4 FY24: reported $0.38 per share against an estimate of $0.3264
  3. Q1 FY25: reported $0.33 per share against an estimate of $0.2976
  4. Q2 FY25: reported $0.41 per share against an estimate of $0.348
  5. Q3 FY25: reported $0.47 per share against an estimate of $0.3998
  6. Q4 FY25: reported $0.44 per share against an estimate of $0.3501
  7. Q1 FY26: reported $0.54 per share against an estimate of $0.40
  8. Q2 FY26: reported $0.60 per share against an estimate of $0.5481

PRLB news

  • Press releaseBusiness Wire

    Protolabs Sets Conference Call to Discuss Third Quarter 2026 Financial Results

  • Press releaseBusiness Wire

    Protolabs Accelerates the Future of Robotics with Rapid Manufacturing

  • Press releaseBusiness Wire

    Protolabs Named to Business Insider’s America’s Most Innovative Businesses 2027 List

  • Press releaseBusiness Wire

    Protolabs Appoints Sam Ramahi as Chief Operations Officer

  • Press releaseBusiness Wire

    Protolabs Supports MIT Industrial Performance Center Research Fellows to Accelerate U.S. Medical and Aerospace Manufacturing Innovation

  • Press releaseBusiness Wire

    Protolabs Reports Financial Results for the Second Quarter of 2026

  • Press releaseBusiness Wire

    Protolabs Named to TIME’s 2026 List of America’s Best Companies

  • Press releaseBusiness Wire

    Protolabs Sets Conference Call to Discuss Second Quarter 2026 Financial Results

Similar companies

Companies in the same industry as Proto Labs

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.